Zhejiang Ausun Pharmaceutical Co Ltd Cash Flow Conversion Efficiency
Zhejiang Ausun Pharmaceutical Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Zhejiang Ausun Pharmaceutical Co Ltd (603229) has a cash flow conversion efficiency ratio of 0.052x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥121.49 Million ≈ $17.78 Million USD) by net assets (CN¥2.35 Billion ≈ $343.48 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Zhejiang Ausun Pharmaceutical Co Ltd (2012–2025)
Cash flow conversion efficiency of Zhejiang Ausun Pharmaceutical Co Ltd from 2012 to 2025. This chart illustrates how Zhejiang Ausun Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest Zhejiang Ausun Pharmaceutical Co Ltd stock price today for real-time trading data and today's change.
Zhejiang Ausun Pharmaceutical Co Ltd Cash Flow Conversion Ratio Explained
Zhejiang Ausun Pharmaceutical Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Zhejiang Ausun Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zhejiang Ausun Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Also see 603229 market cap for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Plazza AG
SW:PLAN
|
0.016x |
|
Pentamaster Corporation Bhd
KLSE:7160
|
0.040x |
|
Southside Bancshares, Inc.
NASDAQ:SBSI
|
0.048x |
|
Bank Sinarmas Tbk
JK:BSIM
|
0.273x |
|
Odyssey Therapeutics, Inc. Common Stock
NASDAQ:ODTX
|
-0.082x |
|
Hainan Development Holdings Nanhai Co Ltd
SHE:002163
|
-0.094x |
|
Gujarat Pipavav Port Limited
NSE:GPPL
|
0.085x |
|
Simply Good Foods Co
NASDAQ:SMPL
|
0.031x |
Annual Cash Flow Conversion Efficiency for Zhejiang Ausun Pharmaceutical Co Ltd (2012–2025)
The table below shows the annual cash flow conversion efficiency of Zhejiang Ausun Pharmaceutical Co Ltd from 2012 to 2025. Review free cash flow generation of Zhejiang Ausun Pharmaceutical Co Ltd to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥2.27 Billion ≈ $332.08 Million |
CN¥156.51 Million ≈ $22.90 Million |
0.069x | -11.94% |
| 2024-12-31 | CN¥2.27 Billion ≈ $332.45 Million |
CN¥177.93 Million ≈ $26.04 Million |
0.078x | -24.40% |
| 2023-12-31 | CN¥2.14 Billion ≈ $313.38 Million |
CN¥221.85 Million ≈ $32.46 Million |
0.104x | +25.54% |
| 2022-12-31 | CN¥1.46 Billion ≈ $213.81 Million |
CN¥120.57 Million ≈ $17.64 Million |
0.083x | -40.46% |
| 2021-12-31 | CN¥1.25 Billion ≈ $183.62 Million |
CN¥173.90 Million ≈ $25.45 Million |
0.139x | +12.78% |
| 2020-12-31 | CN¥1.13 Billion ≈ $164.90 Million |
CN¥138.47 Million ≈ $20.26 Million |
0.123x | -9.63% |
| 2019-12-31 | CN¥645.19 Million ≈ $94.41 Million |
CN¥87.73 Million ≈ $12.84 Million |
0.136x | +606.38% |
| 2018-12-31 | CN¥597.60 Million ≈ $87.45 Million |
CN¥11.50 Million ≈ $1.68 Million |
0.019x | -76.76% |
| 2017-12-31 | CN¥564.93 Million ≈ $82.67 Million |
CN¥46.78 Million ≈ $6.85 Million |
0.083x | -78.38% |
| 2016-12-31 | CN¥243.30 Million ≈ $35.60 Million |
CN¥93.21 Million ≈ $13.64 Million |
0.383x | +34.36% |
| 2015-12-31 | CN¥188.07 Million ≈ $27.52 Million |
CN¥53.63 Million ≈ $7.85 Million |
0.285x | +3.96% |
| 2014-12-31 | CN¥78.21 Million ≈ $11.44 Million |
CN¥21.45 Million ≈ $3.14 Million |
0.274x | -42.62% |
| 2013-12-31 | CN¥32.91 Million ≈ $4.82 Million |
CN¥15.73 Million ≈ $2.30 Million |
0.478x | +534.85% |
| 2012-12-31 | CN¥10.36 Million ≈ $1.52 Million |
CN¥-1.14 Million ≈ $-166.57K |
-0.110x | -- |
About Zhejiang Ausun Pharmaceutical Co Ltd
Zhejiang Ausun Pharmaceutical Co., Ltd. engages in the research and development, process development, manufacture, and sale of APIs and pharmaceutical intermediates. It offers fluorine products, prostaglandins, antimicrobials, and oncology products. The company also provides products for liver disease, respiratory system, and cardiac and cerebral vessels, as well as CNS indications. In addition, … Read more